BRPI0414010A - uso de biotina ou de um derivado de biotina com a finalidade de clareamento da pele e para o trtamento de lentiginas senis - Google Patents

uso de biotina ou de um derivado de biotina com a finalidade de clareamento da pele e para o trtamento de lentiginas senis

Info

Publication number
BRPI0414010A
BRPI0414010A BRPI0414010-9A BRPI0414010A BRPI0414010A BR PI0414010 A BRPI0414010 A BR PI0414010A BR PI0414010 A BRPI0414010 A BR PI0414010A BR PI0414010 A BRPI0414010 A BR PI0414010A
Authority
BR
Brazil
Prior art keywords
biotin
skin
treatment
skin whitening
derivative
Prior art date
Application number
BRPI0414010-9A
Other languages
English (en)
Inventor
Roland Jermann
Helmut Luther
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of BRPI0414010A publication Critical patent/BRPI0414010A/pt
Publication of BRPI0414010B1 publication Critical patent/BRPI0414010B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)

Abstract

"USO DE BIOTINA OU DE UM DERIVADO DE BIOTINA COM A FINALIDADE DE CLAREAMENTO DA PELE E PARA O TRATAMENTO DE LENTIGINAS SENIS". A presente invenção refere-se ao uso de biotina isoladamente, preferencialmente, contudo, com vitamina C ou um derivado de vitamina C, para a preparação de uma composição cosmética ou de uma composição farmacêutica com a finalidade de clareamento da pele, para a eliminação de irregularidades na cor da pele e para o tratamento de lentiginas senis.
BRPI0414010-9A 2003-08-26 2004-08-12 uso cosmético de biotina em conjunto com ascorbil fosfato de sódio ou um hidrato do mesmo para a produção de uma composição para clarear a pele, para corrigir irregularidades na cor da pele e/ou para tratar lentiginas senis BRPI0414010B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03018730 2003-08-26
EP03018730.6 2003-08-26
PCT/EP2004/009048 WO2005020877A2 (de) 2003-08-26 2004-08-12 Verwendung von biotin oder einem biotinderivat zur aufhellung der haut und behandlung von altersflecken

Publications (2)

Publication Number Publication Date
BRPI0414010A true BRPI0414010A (pt) 2006-10-24
BRPI0414010B1 BRPI0414010B1 (pt) 2021-03-16

Family

ID=34203219

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414010-9A BRPI0414010B1 (pt) 2003-08-26 2004-08-12 uso cosmético de biotina em conjunto com ascorbil fosfato de sódio ou um hidrato do mesmo para a produção de uma composição para clarear a pele, para corrigir irregularidades na cor da pele e/ou para tratar lentiginas senis

Country Status (12)

Country Link
US (2) US20050048012A1 (pt)
EP (2) EP1872772B1 (pt)
JP (1) JP4755985B2 (pt)
KR (1) KR101088604B1 (pt)
CN (1) CN1842318B (pt)
AT (1) ATE396695T1 (pt)
BR (1) BRPI0414010B1 (pt)
DE (1) DE502004007294D1 (pt)
ES (2) ES2304161T3 (pt)
MX (1) MXPA06000464A (pt)
PL (1) PL1658039T3 (pt)
WO (1) WO2005020877A2 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007063224A (ja) * 2005-09-01 2007-03-15 Kobayashi Pharmaceut Co Ltd チロシナーゼ活性阻害剤
JP2007063223A (ja) * 2005-09-01 2007-03-15 Kobayashi Pharmaceut Co Ltd しみ又はそばかす予防又は治療用経口組成物及び食品
WO2007051596A1 (en) * 2005-11-03 2007-05-10 Dsm Ip Assets B.V. Novel retinyl biotinates and use thereof
DE102006047157A1 (de) * 2006-09-29 2008-04-03 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninmethylester und einem oder mehreren hautaufhellenden Wirkstoffen gegen unerwünschte Pigmentierung der Haut, insbesondere postinflammatorische Hyperpigmentierung
DE102006047156A1 (de) * 2006-09-29 2008-04-03 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninethylester und einem oder mehreren hautaufhellenden Wirkstoffen gegen unerwünschte Pigmentierung der Haut, insbesondere postinflammatorische Hyperpigmentierung
FR2913198B1 (fr) * 2007-03-01 2009-06-05 Oreal Utilisation cosmetique d'une association de biotine et de vitamine cg.
CN101631593B (zh) * 2007-03-12 2014-08-13 帝斯曼知识产权资产管理有限公司 化妆品组合物
US20100087498A1 (en) * 2007-05-10 2010-04-08 Regina Goralczyk Use of biotin to prevent photoaging
DE102008008554A1 (de) * 2008-02-12 2009-08-13 Sebapharma Gmbh & Co. Kosmetische oder medizinische Zubereitung enthaltend Biotin
JP2009256326A (ja) * 2008-03-21 2009-11-05 Kose Corp 美白剤、及び皮膚外用剤
WO2015195404A1 (en) 2014-06-20 2015-12-23 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for detection of an analyte by movement of tethered microparticles
WO2016205239A1 (en) 2015-06-15 2016-12-22 The United States Of America, As Represented By The Secretary Department Of Health And Human Services Non-hormonal mammalian sperm decoy contraception based on the n-terminus of the zp2 protein
US20170135969A1 (en) 2015-11-12 2017-05-18 Jds Therapeutics, Llc Topical arginine-silicate-inositol for wound healing
AU2017318672B2 (en) * 2016-09-01 2022-03-10 Nutrition 21, Llc Magnesium biotinate compositions and methods of use
CA3041059C (en) 2016-10-21 2023-09-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Molecular nanotags
US10878941B2 (en) * 2017-05-22 2020-12-29 Zeyix Llc Perpetual bioinformatics and virtual colorimeter expert system
WO2019133727A1 (en) 2017-12-29 2019-07-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Universal influenza virus probe set for enrichment of any influenza virus nucleic acid
GB201800909D0 (en) * 2018-01-19 2018-03-07 Biocel Ltd Compositions and methods relating to amnion
CN120360921A (zh) 2018-03-23 2025-07-25 玫琳凯有限公司 局部用组合物和方法
US11246886B2 (en) * 2018-09-06 2022-02-15 Nutrition 21, Llc Treatment of autism and autism spectrum disorders with biotin compositions
WO2021127048A1 (en) 2019-12-16 2021-06-24 Nutrition 21, Llc Methods of production of arginine-silicate complexes
WO2022056078A1 (en) 2020-09-11 2022-03-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Rnase h-assisted detection assay for rna (radar)
CN114504549B (zh) * 2022-02-24 2023-11-24 北京斯利安药业有限公司 生物素的水性凝胶剂及其制备方法和应用
WO2024191684A1 (en) 2023-03-10 2024-09-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Detection of hepatitis c virus ribonucleic acid from whole blood using reverse transcription loop-mediated isothermal amplification

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH656067A5 (de) * 1981-12-10 1986-06-13 Richardson Vicks Inc Kosmetisches haarpflege- oder hautpflegemittel.
JPS6442414A (en) * 1987-08-10 1989-02-14 Kanebo Ltd Skin-beautifying cosmetic
JPH02215707A (ja) * 1989-02-15 1990-08-28 Chisso Corp 皮膚化粧料
GB9006785D0 (en) * 1990-03-27 1990-05-23 Leung Lit Hung Composition and methods for treatment of acne vulgaris and retardation of ageing
IT1254045B (it) * 1991-12-31 1995-09-06 Lifegroup Spa Derivati idrosolubili della biotina e relative composizioni terapeutiche
DE4242876C2 (de) * 1992-12-18 1997-11-27 Beiersdorf Ag Kosmetische und/oder dermatologische Zubereitungen zur kosmetischen und/oder dermatologischen Pflege der Haut und/oder der Hautanhangsgebilde
JPH0797322A (ja) * 1993-09-29 1995-04-11 Shiseido Co Ltd 一重項酸素消去剤
JPH07233046A (ja) * 1993-12-28 1995-09-05 Kose Corp 外用剤
DE4444238A1 (de) * 1994-12-13 1996-06-20 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
WO1997025883A1 (de) * 1996-01-17 1997-07-24 Friedrich Kisters Aminosäuren-präparat zur haarwuchsförderung
DE19701651A1 (de) * 1997-01-18 1998-07-23 Rovi Gmbh Handelsgesellschaft Wäßrige Zusammensetzung mit biotinhaltigen Liposomen
IN2000KO00299A (pt) * 1999-05-28 2005-11-18 Johnson & Johnson Consumer
US6551604B1 (en) * 1999-06-28 2003-04-22 The Procter & Gamble Company Skin care compositions
DE19941769A1 (de) * 1999-09-02 2001-03-08 Beiersdorf Ag Wirkstoffkombinationen bzw. Addukte aus Biotin und/oder Biotinderivaten und Cyclodextrinen und Verwendung solcher Wirkstoffkombinationen in kosmetischen Zubereitungen
JP4786127B2 (ja) * 2002-07-12 2011-10-05 任康 高田 色素沈着改善治療薬
CN1816287A (zh) * 2003-01-31 2006-08-09 宝洁公司 改善哺乳动物角质组织外观的方法
EP1449514A1 (de) * 2003-02-13 2004-08-25 Beiersdorf AG Hautpflegeprodukte mit Retinoiden, Ubichinonen sowie Biotin oder Carnitin

Also Published As

Publication number Publication date
EP1872772A1 (de) 2008-01-02
JP4755985B2 (ja) 2011-08-24
EP1658039B1 (de) 2008-05-28
PL1658039T3 (pl) 2008-10-31
BRPI0414010B1 (pt) 2021-03-16
WO2005020877A2 (de) 2005-03-10
EP1872772B1 (de) 2015-08-05
JP2007503407A (ja) 2007-02-22
DE502004007294D1 (de) 2008-07-10
US20070020206A1 (en) 2007-01-25
CN1842318B (zh) 2011-04-13
ES2304161T3 (es) 2008-09-16
CN1842318A (zh) 2006-10-04
EP1658039A2 (de) 2006-05-24
MXPA06000464A (es) 2006-04-11
ES2547852T3 (es) 2015-10-09
US20050048012A1 (en) 2005-03-03
WO2005020877A3 (de) 2005-07-14
KR101088604B1 (ko) 2011-11-30
KR20060069472A (ko) 2006-06-21
ATE396695T1 (de) 2008-06-15

Similar Documents

Publication Publication Date Title
BRPI0414010A (pt) uso de biotina ou de um derivado de biotina com a finalidade de clareamento da pele e para o trtamento de lentiginas senis
US8568749B2 (en) Systems and methods for skin rejuvenation
WO2004068970A3 (en) Means for improving the appearance of mammalian keratinous tissue
BRPI0519195A2 (pt) composiÇço de cuidado oral, e, mÉtodo para prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal
BRPI0416052A (pt) composição para tratamento de pele contendo ácido deidro acético e ativos para tratamento de pele
BRPI0408062A (pt) regulação de tecido queratinoso de mamìferos usando composições com hexamidina
DE59504241D1 (de) Kombinationspräparat zur förderung des haarwachstums und ggf. des haut- und nagelwachstums sowie zur verhinderung bzw. zur beseitigung von haarausfall
GB0420888D0 (en) Compounds and uses
AU2019204136B2 (en) Compositions and methods for treating skin conditions using light and glucosamine hydrochloride
Bellad et al. Development ofcosmeceuticals
WO2004071538A3 (en) Topical delivery of cosmetic agents
MXPA03010429A (es) Producto topico con indicador visual.
BR0306306A (pt) Composição contendo extrato de matricária e uso desta
EP1192949A4 (en) PREVENTIVE OR THERAPEUTIC DRUGS FOR TREATING FIBROSIS AND CONTAINING CHYMASE INHIBITORS AS ACTIVE INGREDIENTS
EP1074245A3 (en) Composition using mineral salts for therapeutic treatment
JP7214350B2 (ja) 光及びポリカルボン酸を使用して皮膚疾患を治療するための組成物及び方法
MX2007014427A (es) Regulacion del tejido queratinoso de mamiferos utilizando activos para el cuidado de la piel o el cabello.
CA2494473A1 (en) Stabilized protein compositions for topical administration and methods of making same
TW201424764A (zh) 膠原蛋白刺激物及其於處理皮膚之用途
BRPI0418764A (pt) uso de espinosina ou um derivado ou sal da mesma fisiologicamente aceitável
ES2169942T3 (es) Uso de preparaciones topicas de trinitrato de glicerilo y lanolina para el tratamiento de la disfuncion erectil.
BR0316029A (pt) Combinação
WO2007050423A3 (en) Skin rejuvinating supplement
RU2793250C2 (ru) Композиция и способы лечения патологических состояний кожи; использование света и гидрохлорида глюкозамина
DE602004030725D1 (de) Dermatologische und/oder kosmetische zusammensetzung mit polypeptiden

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O ARTIGO 8O C/C 11 E 8O C/C 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/375 (2006.01), A61K 8/67 (2006.01), A61K 3

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 16/03/2021, OBSERVADAS AS CONDICOES LEGAIS.